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ABSTRACT 
 
       MosA is an enzyme from Sinorhizobium meliloti L5-30, a beneficial soil bacterium.  
Initial investigation into this enzyme categorized it as a methyltransferase.  Further 
investigation revealed that this was incorrect, and that MosA is actually a 
dihydrodipicolinate synthase, part of the N-acetylneuraminate lyase superfamily.  One of 
the characteristics of enzyme superfamilies is their low sequence identity, but relatively 
high structural similarity.  The structural investigation reported here confirms the high 
structural similarity between MosA and other superfamily members.   
       Investigation of MosA was carried out by means of x-ray crystallography.  It was 
believed that detailed structural information may shed light into not only the enzymatic 
mechanism, but also the inhibition of MosA by lysine, the final product of the enzymatic 
pathway.  Insight into enzyme mechanism and inhibition may ultimately prove useful in 
herbicide or insecticide development, as other dihydrodipicolinate synthases from 
harmful fungi, bacteria, or plants, make attractive targets for inhibition.  Lysine is an 
essential amino acid for humans, meaning that there is no endogenous lysine production 
to block the use of these hypothetical inhibitors.  Specific inhibitors based on crystal 
structures have proven to be effective in the past and hopefully, will continue to be useful 
in the future. 
       Here we report the structure of MosA, solved to 1.95 Å resolution with lysine 161 
forming a Schiff-base adduct with pyruvate.  This adduct is consistent with the currently 
accepted dihydrodipicolinate synthase enzyme mechanism.  
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1.0   Introduction 
Proteins serve an important role in the proper functioning of all living organisms.  
Most enzymes are proteins that catalyze chemical reactions.  By reducing the activation 
energy of a specific chemical reaction, enzymes facilitate chemistry that is vital for an 
organism’s survival.  Enzymes are also capable of stereo-specific reactions that would be 
virtually impossible to achieve in their absence.   
       In 1958, myoglobin was the first protein structure solved using X-ray crystallography 
(Kendrew et al., 1958).  In the following years, it became apparent that solving a protein 
or enzyme’s structure could yield highly useful information.  By understanding the 
mechanism, specifically the residues involved, insight into an enzyme’s function and 
regulation can be gained.  This insight can lead to advancements in drug design, 
development of more economical enzyme reactions for industrial use, or even the 
creation of new vaccines. 
       
1.1   N-acetylneuraminate lyase (NAL) superfamily 
        An enzyme superfamily has certain characteristics, for example, a low level of 
sequence identity, but a similar fold with similar active site residues in a conserved 
orientation (Lawrence et al., 1997).  In addition, some superfamilies, like the enolase 
superfamily, share common structural architecture but catalyse a wide range of different 
reactions (Babbitt and Gerlt, 1997).  N-acetylneuraminate lyase itself is a class I aldolase 
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found in numerous organisms that catalyses the cleavage of N-acetylneuraminate to N-
acetyl-D-mannose and pyruvate (Figure 1.1).   
        
 
Figure 1.1 The N-acetylneuraminate lyase reaction (adapted from Barbosa, 2000).  
Shown on the left side of the reaction is N-acetyl-neuraminate in linear and ring form.  
On the right side of the reaction are the two products, N-acetyl-D-mannose and pyruvate.        
 
       The NAL superfamily consists of hundreds of enzymes with similar overall structural 
homology, folding into a triose phosphate isomerase (TIM) barrel (Banner et al., 1975) 
(reviewed by Reardon and Farber, 1995) (Figure 1.2) and a wide range of differing 
reactions (Figure 1.3).  These reactions include the use of an electron sink strategy 
employed in aldol condensation, dihydrodipicolinate synthase, and dehydratase/ 
decarboxylase (Babbitt and Gerlt, 1997).  These reactions utilize Schiff base formation 
and in the case of NAL, a Schiff base is formed and a new double bond is produced in the 
product. Imine or Schiff base formation is a common enzyme intermediate in the NAL 
superfamily (Lawrence et al, 1997) (Figure 1.3).   
 2
  
 3
  
Figure 1.2 Overall E. coli DHDPS folding (1DHP).  Above, the single subunit, two 
interconnected subunits, and homotetramer show similar folding to other known NAL 
family members.  The (β/α)8  TIM barrel motif, characteristic of the NAL superfamily, is 
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evident.  The outer 8 α helices wrap around 8 parallel β strands, orienting the key active 
site residues pictured in green.   
 
Figure 1.3 Generic Schiff base formation reaction.  A carbonyl group undergoes 
nucleophilic attack from an amino group nitrogen followed by a dehydration facilitated 
by a nearby acid.  
   
1.1.1   Dihydrodipicolinate synthases (DHDPSs)  
        DHDPSs are aldolases catalyzing the condensation of L-aspartate-β-semialdehyde 
(L-ASA) to pyruvate and dihydrodipicolinic acid.  In a ping-pong mechanism, DHDPS 
utilizes an imine intermediate in the reaction (Figure 1.3).  There are currently twelve 
DHDPS structures reported in the Protein Data Bank, originating from five different 
organisms.  First solved in 1995, DHDPS from Escherichia coli (E. coli) (1DHP) 
(Mirwaldt et al., 1995), shares a 45% identity with MosA, the DHDPS from 
Sinorhizobium meliloti (S. meliloti).  Seven DHDPS structures deposited are from E. coli, 
six of them being mutants that reduce enzymatic activity (1S5T, 1S5V, 1S5W, Dobson et 
al., 2004a; 2A6L, 2A6N, Dobson et al., 2005a; 2OJP).  T44V, Y107F, Y133F mutants 
showed a marked reduction in activity, confirming the notion of a catalytic triad made up 
of V44, Y107, and Y133 (Dobson et al., 2004a).  The exact function of R138 in the 
enzyme mechanism is unknown, but it is suspected that R138 may play a role in L-ASA 
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binding.  To examine the possible role of R138, two mutants were constructed, R138H 
and R138A, both showing reduced activity and lending credence to the theory that R138 
does play a vital role in stabilizing the catalytic triad (Dobson et al., 2005a). The question 
of L-ASA binding, and the possible role R138 would play, remains unanswered. 
        There are two non-mutated E. coli DHDPS structures that have been deposited, the 
native (1DHP), and a ligand bound structure containing two lysine amino acids bound at 
the allosteric site (1YXD)(Dobson et al., 2005b).  As discussed in Section 1.1.3, DHDPS 
from E. coli and MosA from S. meliloti are involved in the biosynthesis of lysine.  As 
such, lysine, as the end product, is a negative feedback inhibitor of DHDPS from E. coli 
and MosA from S. meliloti.   
       All of the reported structures share an overall structural similarity.  A multiple 
sequence alignment shows the overall identity and homology between MosA and other 
DHDPSs, the highest sequence identity being 45% with 1DHP, the E. coli DHDPS 
(Figure 1.4).  The structure of MosA, the DHDPS from S. meliloti reported here, also 
shares a high degree of structural homology, confirming its place in the DHDPS family.  
As seen in Figure 1.5, structural overlays between currently solved DHDPSs and E. coli 
DHDPS show similarities, including the overall TIM barrel motif.  Further discussion on 
E. coli DHDPS and MosA is found in Section 4.2.1.  NAL from Haemophilus influenzae 
(H. influenzae) was solved in 2000 with three inhibitors bound (Barbosa et al., 2000).  
Comparisons between MosA and this NAL are discussed in Section 4.2.2.; however, as 
seen in Figure 1.5, a structural overlay of the Cα atoms of E. coli DHDPS and H. 
influenzae NAL reveals some differences in helix positioning, but overall structural 
similarity.  Of further interest in the H. influenzae NAL structure is the presence of three 
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different inhibitor molecules, bound in separate structures.  One inhibitor is sialic acid 
alditol (2,4,6,7,8,9-hexahydroxy-5-methyl-methylcarboxamido nonanoic acid: HMN), 
which binds directly to the active site and provides some insight into possible 
mechanisms of inhibition (Figure 1.6)(Figure 4.9, 4.10)(pg. 58,59).  In addition to E. coli 
and H. influenzae, structures of DHDPS from Thermatoga maratima (T. maratima) 
(1O5K) (Figure 1.5); DHDPS from Mycobacterium tuberculosis (M. tuberculosis) 
(1XXX) (Figure 1.5) (Kefala et al., 2008); and DHDPS from Aquifex aeolicus (A. 
aeolicus) (2EHH) (Figure 1.5), have been solved.  Compared with the structure of MosA 
discussed in this thesis, all show folding similarities, and would seem to confirm MosA 
as a member of this enzyme family. 
        Initial investigation into MosA function resulted in a sequence being published 
which was somewhat erroneous, with a frame shift causing forty C-terminal amino acids 
to be removed (Rao et al., 1995) (Tam et al., 2004).  Complementation and deletion 
experiments identified MosA as a methyltransferase (Rao et al., 1995).  This seemed to 
defy conventional thinking about enzyme superfamilies, as MosA belonged to the NAL 
superfamily.  While sequence may vary in a superfamily, the overall set of reactions 
tends to be conserved.  No other NAL superfamily member is a methyltransferase.  Work 
in the Palmer laboratory revealed the original error in the reported sequence.  The new 
sequence was deposited and MosA enzyme activity was assayed.  After confirming 
aldolase activity, further work with isothermal titration calorimetry revealed no 
interaction between MosA and its supposed methyltransferase substrates (Phenix, 2007).  
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 Figure 1.4 Sequence alignment of MosA, the DHDPS from S. meliloti, and other NAL 
family members for which the structure is known.  The alignment was generated using 
Clustalw2 with the gonnet scoring matrix (gap penalty 10, gap extension penalty 0.2), 
and visualized with Jalview (Clamp et al., 2004).  Identical and homologous residues 
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shown in blue, darkest blue identity, lighter blue showing similarity.  Active site residues 
denoted with an asterisk.  
  
 
Figure 1.5 Multiple overlay of all currently solved NAL/DHDPS family members.  
Shown from the top and side, the TIM barrel motif is evident in all of the enzymes from 
the NAL superfamily currently solved.   Pictured are MosA (green), E. coli DHDPS 
(1DHP; light blue), A. aeolicus DHDPS (2EHH; magenta), T. maritima DHDPS (1O5K; 
yellow), M. tuberculosis DHDPS (1XXX; peach), and H. influenzae NAL (1F73; dark 
blue).  Final r.m.s.d values ranged from 1.2 – 2.3 Å and can be found with the residue 
ranges used in Table 3.5. 
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 Figure 1.6 Diagram of sialic acid alditol (HMN). 
 
1.1.2   MosA 
        MosA is the DHDPS found in S. meliloti (Dixon, 1969).  It was originally 
misidentified as a methyltransferase (Rao et al., 1995) but research done in recent years 
has confirmed MosA is indeed a DHDPS.  The MosA subunit has a molecular mass of 
around 33.4 kDa and, like other members of the NAL superfamily, has a classic TIM 
barrel tertiary structure. MosA aldolase activity was confirmed with a Km of around 0.27 
mM for pyruvate and a 0.13 mM for L-ASA (Tam et al., 2004).   
       The proposed mechanism of action involves a Schiff base intermediate, like other 
members of the NAL superfamily (Babbitt and Gerlt, 1997).  Key active site residues are 
T43, T44, Y106, Y132, R137, K161, G186 and I203 (S. meliloti numbering).  As seen in 
Figure 1.7, the active site residues centre around K161, as pyruvate forms an imine with 
the lysine side chain, completing the first step of the reaction.  Reported in this thesis, the 
structure of MosA with pyruvate bound is the first such structure deposited in the Protein 
Data Bank.  This imine intermediate has been documented (Borthwick et al., 1995; Laber 
et al., 1992), but has never been captured before via protein crystallography.  This thesis 
reports the imine of pyruvate and lysine bound at the active site, which tends to confirm 
 10
the currently accepted mechanism of action (Figure 1.8) and supports the role of MosA in 
the lysine biosynthetic pathway as a DHDPS.  Inhibition of DHDPSs by lysine has been 
documented (Dobson et al., 2004b; Yugari and Gilvarg, 1965), and was proven to occur 
at an allosteric site (Figure 1.11) (Figure 4.9; pg. 57).  This allosteric site is located at the 
outside edge of the E. coli dimer; however, the mechanism of lysine inhibition via 
binding to the allosteric site remains unknown.  
        
 
Figure 1.7 View of the MosA active site.  Key active site residue carbons are shown in 
green, oxygens red, and nitrogen blue.  
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 Figure 1.8 The accepted mechanism of DHDPS enzyme activity.  Pyruvate binds via 
nucleophilic attack by the Nε on K161, highlighted in the green box.  A Schiff base is 
formed following a dehydration step with Y133 (E. coli numbering) forming a catalytic 
triad with T44 and Y107; acting first as a Lewis acid to stabilize the carbonyl oxygen 
intermediate, then later as a Brønsted-Lowry acid in the activation of L-ASA.  Enamine 
formation is the end result of pyruvate binding and the activation of a methyl carbon 
hydrogen by the carbonyl oxygen of I203 with the proton picked up by solution. With the 
pyruvate covalently bound to K161, L-ASA binds via hydrogen bonds with G186 and 
Y133.  Following carbonyl formation, an attack from the methylene electrons binds the 
pyruvate and L-ASA together, with the carbonyl oxygen of G186 acting as a Lewis base.  
Y133 transfers a proton to the amino group of L-ASA, which then attacks the Shiff base 
complex, completing the cyclization.  Y133 is regenerated with a proton from Nε, which 
itself is regenerated following detachment of (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-
dipicolinic acid (HTPA) (adapted from Dobson et al., 2005b).  
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 Figure 1.9 Stereo view of the E. coli DHDPS dimer.  Active site residue carbons are 
pictured in green, allosteric site residues in light blue.  Located on the exterior of the 
enzyme (right side of the picture), the allosteric site is located more than 5 Å from the 
active site (center of the molecule).  Nitrogens are pictured in dark blue, oxygens in red.  
 
 
1.1.3   Lysine biosynthesis 
        The production of lysine in any organism is vital to its survival.  Lysine is an 
essential amino acid for humans, resulting in a need to obtain lysine from primarily 
dietary sources.  In the case of S. meliloti, MosA is inhibited by lysine with a Ki of about  
0.7 mM (Phenix, 2007).  Binding of lysine to MosA complexed with pyruvate is 
cooperative, with the second lysine binding giving a large exothermic enthalpy value 
(Phenix, 2007).  Lysine binding was also shown to be non-competitive with respect to 
pyruvate, supporting earlier work done by Dobson (Dobson et al., 2005b).  Inhibition by 
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lysine is discussed in Section 4.2.1.1, but shown in Figure 1.9; binding occurs at an 
allosteric site in E. coli DHDPS.  This site is located at the outer edge of the E. coli 
DHDPS dimer, and thus the outer edge of the tetramer, but contrary to earlier reports, no 
channel or direct connection can be observed (Dobson et al., 2005b).   
       DHDPS is found in the diaminopimelate pathway, which is the lysine-producing 
pathway in lower fungi, bacteria, and green plants (Scapin and Blanchard, 1998).  It is for 
this reason that inhibition of key enzymes is increasingly attractive to researchers looking 
for novel antibiotics and herbicides (Coulter et al., 1999; Cox et al., 2000; Hutton et al., 
2003).  Humans have no endogenous lysine production, and thus do not have a DHDPS 
that would be inhibited by an antibiotic or herbicide developed in this fashion.  While S. 
meliloti is a beneficial soil bacterium, structural similarities between DHDPSs make 
investigation into this particular enzyme valuable (Dixon, 1969). 
 
1.1.4 Objectives 
       After work in Palmer laboratory revealed that MosA was a member of the DHDPS 
family of enzymes, it was clear that further information was needed.  Structural 
investigation of MosA was undertaken to provide answers into mechanism of action, and 
inhibition by lysine.  Answers to the role of R137 in enzyme activity and L-ASA binding 
were also sought out, given the current debate in the literature.  Given that DHDPS 
family members make attractive drug targets, further information about the DHDPS 
family, including MosA, would prove valuable.  
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1.2   Methods of X-ray Crystallography 
       Crystals are regularly repeating units of identical shape and size.  They can be 
categorized into fourteen Bravais lattices.  In crystals, the smallest repeating unit that 
arranges in these space groups is called an asymmetric unit.   This regular packing is 
what allows researchers to gain information about the protein by placing the crystal in a 
high-energy X-ray beam (>12 KeV).  These X-rays are generated either by a rotating 
anode source, in the researcher’s lab, or by a synchrotron.  The latter of these produces 
X-rays of very high intensity and low divergence.  The theory is that electrons around the 
atoms absorb the electromagnetic radiation, and then re-emit that radiation, at the same 
energy along a new vector.  Because crystals are essentially a three-dimensional 
diffraction grating, a diffraction pattern can be used to determine information about the 
unit cell in that crystal, including the shape of the electron clouds that diffracted those X-
rays i.e. the protein structure.  A space group is the three-dimensional arrangement of the 
molecules in the unit cell.  By combining the Bravais lattices with all the point groups, 
and allowing symmetry elements such as translations, screw axes, and glide planes, there 
are 230 possible space groups but because proteins molecules are chiral, they can only 
crystallize in 65 possible space groups.   
 
1.2.1   Diffraction 
       Diffraction of X-rays occurs when electrons surrounding atoms in a molecule absorb 
and re-emit X-rays.  W. L. Bragg showed that X-ray reflections could be observed using 
specific incident angles and wavelengths when a crystal is placed in front of them (Bragg, 
W. H. and Bragg, W. L., 1913).  Furthermore, Bragg showed that modeling a set of 
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parallel planes separated by a set perpendicular distance d, a peak of X-ray intensity 
would be observed if the reflection off those planes interfered constructively.  A reflected 
beam will occur at an incident angle θ and a reflected angle θ with respect to the planes, 
and at an angle 2θ from the direct beam as described in Bragg’s Law (2.1).   
2dhklsinθ = nλ                                                                                2.1       
       The indices h, k, and l refer to the number of planes in the set per unit cell, in the x, y, 
and z directions respectively.  The interplanar spacing is thus dhkl and the x-ray 
wavelength λ, and n is an integer, 1, 2, 3 ….  The resulting diffraction pattern is a result 
of all the atomic scattering contributions.  The scattering observed is dependent on the 
location and type of each atom in the unit cell.  Each atom’s ability to scatter X-rays can 
be described by the equation 2.2.   
              (r)e∫=
r
f ρ (2πir• S)dr                                                                     2.2 
       The scattering factor then is dependent on ρ(r), the electron density at position r, and 
|S|, where |S|= (2sinθ)/λ.  The vector summations of all the scattering are called the 
structure factors ( ).   )(SF
                                    exp(2πir∑
=
=
n
j
jefSF
1
)( j• S)                                                         2.3 
       The structure factor depends on atom type and location.   The intensity of the 
diffracted X-rays measured is proportional to the square of the structure factor 
amplitudes.  A Fourier transform can be used to describe the relationship between 
reciprocal space and real space.  A crystal’s diffraction pattern is a Fourier transform of 
the crystal, and more specifically, of its electron density.  The electron density at position 
x, y, z [ρ(xyz)] in the crystal is thus the Fourier transform of the structure factors . )(hklF
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                              ∫ ∫ ∫ ++−=
h k l
dhdkdllzkyhxihklF
V
xyz )](2exp[)(1)( πρ                      2.4 
 
Because data are produced at distinct locations, the integral can be reduced to a Fourier 
summation. 
                               ∑∑∑ +++−=
h k l
hklilzkyhxihklF
V
xyz )]()(2exp[|)(|1)( απρ     2.5 
V is the volume of the unit cell and each structure factor, , describes a specific 
reflection in the diffraction pattern.  Each term in the above summation is a three-
dimensional wave with frequency h in the x direction, k in the y direction, and l in the z 
direction.  These waves, different with each hkl value, have amplitude F
)(hklF
hkl and phase αhkl.  
Intensities are measured during an experiment.  These intensities are proportional to |Fhkl|.  
There is no lens to focus diffracted X-rays, and thus no way to obtain the phase angles 
directly through experimental data collection.  The result is that other means of 
estimating phases (αhkl) must be employed.  This is known as the phase problem in 
crystallography. 
       A set of parallel planes in the crystal will diffract identically giving rise to one 
reflection.  The crystal is placed at the centre of the Ewald Sphere of Reflection, and 
since reflections observed satisfy the Bragg equation, they represent where the reciprocal 
lattice points touch the sphere (Figure 1.10). Therefore, examination of the diffraction 
pattern observed can yield information about the crystal lattice.   
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Figure 1.10 Diagram illustrating general indices of reflections as they intercept the 
Ewald Sphere.  By rotating the crystal during experimentation, different lattice points 
intercept the sphere, satisfying Bragg’s Law, and producing a reflection.  Depicted are the 
views of these lattice points as they would appear on an X-ray detector (adapted from 
Jeffrey, 2006). 
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1.2.2   Solution of Structure 
1.2.2.1   Molecular Replacement 
        The most common method of solving the phase problem of protein crystals is called 
molecular replacement.  By using phase information from a previously solved protein 
structure, one can approximate the phases for the protein of interest.  Provided an amino 
acid identity of at least 25% to the protein of interest is present (McCoy et al., 1997), the 
relative atomic positions of the search model should provide enough information to solve 
the structure of the protein of interest.  To do this, the Patterson function (P(uvw)) of each 
molecule is compared. 
                           )](2cos[|)(|
V
1)( 2 lwkvhuhklFuvwP
hkl
++= ∑ π                                 2.6 
       The Patterson function is the summation of the square of the structure factor 
amplitudes with all phase angles equal to zero.  Due to the fact that all phase angles of a 
Patterson function are set to zero, it is possible to calculate a Patterson function for an 
unknown protein, with no prior phase information needed.  Each peak in the Patterson 
function is the product of two atomic scattering factors separated by the vector (u,v,w).  
In simpler terms, the Patterson function is a pairwise sum of interatomic vectors, each 
corresponding to the electron density of the two contributing atoms.  A Patterson peak 
thus corresponds to a vector between two atoms within the unit cell.  Small distances 
between atoms in the same protein molecule will create small vector distances, and are 
called self-Patterson vectors.  These intramolecular vectors are used in determining the 
correct rotation parameters from the search model which are applied to the protein of 
interest.  Large intermolecular distances between atoms will create large vector distances, 
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called cross-Patterson vectors, and are used in the determination of the correct translation 
parameters. 
       A Patterson function is calculated for the starting model and then for a large number 
of different orientations of that same model.  The best solution will have a good overlap 
between the search model’s Patterson function, and the Patterson function of the 
unknown protein.  Using self-Patterson vectors, the correct rotation is calculated first.  
The second step is to use the cross-Patterson vectors within the unit cell to determine the 
correct translation.  Obtaining calculated phases from the newly rotated and translated 
model allows an electron density map to be calculated for the unit cell of the protein of 
interest.  An electron density map is calculated by performing a Fourier transform on the 
structure amplitudes and calculated phases. 
 
1.2.2.2 Refinement of Structure  
       Once an electron density map is obtained, the researcher must adjust the model of the 
protein into the density using three-dimensional modeling software.  Initially, it may not 
be possible to see electron density for all of the atoms, side chains, carbonyl oxygens, or 
even continuous density along the α-carbon backbone.  Because data are usually cut off at 
around 2.5 Å for initial molecular replacement, side chain density may not always be 
present.  If the data are not limited in resolution, a molecular replacement solution may 
not be found.  Should the electron density not be continuous, the crystallographer must 
modify the electron density.  This can be accomplished by several techniques, mostly by 
a combination of them all.   
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       The model can be adjusted into as much electron density as is possible, and then new 
phases calculated from those improved atomic positions.  The original phases may be 
combined with the calculated phases to improve the starting point, and allow the model to 
be readjusted into the density generated from the new combined phases.  If the model fits 
closer to the actual structure, the phases generated from it will also improve, allowing the 
cycle to continue.  A figure of merit may be assigned to the phases based on the cosine of 
the phase error.  As the error gets smaller, the figure of merit approaches a value of 1.  
This number serves to monitor the phase combination process, and is a useful tool in 
solving the structure. 
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2.0   Materials and Methods 
2.1   Reagents, Supplies, and Equipment 
       Reagents, supplies, and equipment used in the described experiments are listed in 
Table 2.1.  The commercial suppliers and their addresses are listed in Table 2.2. 
 
2.2   Crystal Structure of MosA complexed with pyruvate 
2.2.1   Protein Purification 
       The mosA gene was cloned, by Chris Phenix in the Palmer laboratory, by PCR-
amplification and sub-cloned into a pET-28b expression vector containing an N-terminal 
poly-histidine tag (Tam et al., 2004).  Recombinant protein was expressed in E. coli BL-
21(DE3) and pelleted cells were lysed in a buffer containing 50 mM Tris-HCl (hydroxy-
methyl)-aminomethane (Tris buffer), pH 8.0, 10 mM imidazole, 500 mM NaCl, and 
12.5% v/v glycerol.  A Chelating Sepharose FF column charged with Ni 2+ and an EDTA 
gradient were used to purify MosA from native proteins.  Dialysis against 50 mM Tris-
HCl, pH 8.0, and a DEAE-Sepharose FF column with an NaCl gradient were used to 
further purify MosA. 
 Enzyme activity was assayed (as described by Borthwick et al., 1995) and 
aspartate ß-semialdehyde (ASA) was synthesized by the method of Roberts (Roberts et 
al., 2003).  MosA was then frozen in solution at –80˚C with a 10% v/v glycerol solution 
used as cryoprotectant. 
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  Table 2.1 Table of biological and chemical reagents, supplies, and equipment. 
_______________________________________________________________________ 
Item                                                                                                                    Supplier___ 
Chemical Reagents 
 
Ammonium Sulfate                                                                                            EM Science 
Glycerol                                                                                                       Fisher Scientific 
Imidazole                                                                                                                     Fluka 
Isopropyl-β-D-thiogalactopyranoside (IPTG)                                                             Sigma 
Lysine                                                                                                                          Sigma 
2-mercaptoethanol                                                                                                       Sigma 
3-[N-Morpholino]propanesulfonic acid (MOPS)                                                        Sigma 
Nickel-nitrilotriacetic acid (Ni-NTA)                                                                        Qiagen 
Nitrogen (liquid)                                                                                                         Praxair 
Luria broth                                                                                                      Sigma-Aldrich 
Polyethylene Glycol 400                                                                                               Fluka 
Potassium Carbonate (K2CO3)                                                                                     Sigma 
Potassium Chloride (KCl)                                                                                             BDH 
Pyruvate                                                                                                                       Sigma 
Sodium Chloride (NaCl)                                                                                          BioShop 
Sodium Phosphate Monobasic (NaH2PO4)                                                              BioShop 
Tris-HCl (hydroxy-methyl)-aminomethane (Tris)                                                   BioShop 
 
Supplies and Equipment
 
Bench-model pH meter, Corning 125                                                              Dow Corning 
Chelating Sepharose FF column                                                                   AP Biosciences 
Cryoloops                                                                                                                Hampton 
DEAE-Sepharose FF column                                                                       AP Biosciences 
Dow Corning High Vacuum Grease                                                                             VWR 
DynaPro-MS800                                                                                                     Proterion 
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Falcon Tubes                                                                                                                 VWR 
Microcentrifuge tubes                                                                                                   VWR 
Micro Cover Glass (No. 1, 22 mm square)                                                                   VWR 
NAP-25 columns                                                                                        Pfizer-Pharmacia 
Silicon Graphics Indigo2 computer                                                                                 SGI 
24-Well VDX plates                                                                                                Hampton 
X8 Proteum                                                                                                        Bruker AXS 
________________________________________________________________________ 
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Table 2.2 Table of names and addresses of suppliers. 
________________________________________________________________________ 
Company                                                           Address____________________________ 
AP Bioscience                                               Amersham Bioscience, Piscataway, NJ, USA 
BDH                                                                British Drug House, Saskatoon, SK, Canada  
BioShop                                                      BioShop Canada Inc., Burlington, ON, Canada  
Bruker AXS                                                              Bruker AXS, Inc., Madison, WI, USA 
Dow Corning                                                         Dow Corning Corp., Midland, MI, USA 
EM Science                                                          EM Industries Inc., Gibbstown, NJ, USA 
Fisher Scientific                          Fisher Scientific Company Canada, Ottawa, ON, Canada   
Fluka                                                     Sigma-Aldrich Canada Ltd., Oakville, ON, Canada 
Hampton                                                       Hampton Research, Lugana Niguel, CA, USA 
Pfizer-Pharmacia                                                               Pfizer Inc., New York, NY, USA 
Praxair                                                                                 Praxair, Saskatoon, SK, Canada 
Proterion                                                Wyatt Technology Corp, Santa Barbara, CA, USA 
SGI                                                          Silicon Graphics Inc., Mountain View, CA, USA 
Sigma                                                                 Sigma Chemical Co., St. Louis, MO, USA 
Sigma-Aldrich                                      Sigma-Aldrich Canada Ltd., Oakville, ON, Canada 
VWR                                                                                  VWR, Mississauga, ON, Canada 
________________________________________________________________________ 
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2.2.2   Crystallization conditions 
         MosA protein, purified as described in Section 2.2.1, was screened using 
Hampton’s Screen Kit 2 (Jancarik and Kim, 1991; Cudney et al., 1994).  Final 
crystallization conditions were optimized from the most promising results of this screen.  
Orthorhombic MosA crystals used in diffraction were grown using an optimized well 
solution of 2 M ammonium sulfate, 100 mM Tris buffer pH = 8.0, and 2% v/v 
polyethyleneglycol 400 (PEG400).  The well solution was then mixed with the protein 
solution in a 1:1 ratio and crystals grew overnight at room temperature.   
        Trigonal MosA crystals were grown in 2 M ammonium sulfate, 100 mM Tris buffer 
pH = 8.0, and 2% v/v PEG400.  The well solution was mixed in a 1:1 ratio with the 
protein solution and crystals grew overnight at room temperature. 
 
2.2.3   Cryoprotection and soaking of crystal samples 
       Crystals were harvested and soaked at room temperature in a cryoprotectant solution 
consisting of 2 M ammonium sulfate, 100 mM Tris buffer, 2% v/v PEG400, 10% 
glycerol, 100 mM pyruvate, and 100 mM lysine. Crystals were soaked for 10 minutes and 
then flash cooled in liquid nitrogen.  Trigonal MosA crystals were previously grown 
using these same conditions as described in Section 2.2.2, and were soaked in the same 
manner as orthorhombic crystals, then diffracted as described in Section 2.2.4. 
 
2.2.4   Data Collection and Processing 
       X-ray data were collected at the Canadian Light Source beamline 08ID-1 for 
orthorhombic MosA crystals soaked with pyruvate and lysine.  Data were collected in a 
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nitrogen stream at 105 K using a MAR225 CCD detector.  A total of 360 images were 
collected with 0.5 degree oscillation per image around the omega axis.  A wavelength of 
1.33 Å was used.  The data were indexed using XDS and then integrated using Mosflm 
(Leslie, 1992).  The data were finally scaled using XDS (Kabsch, 1993) (Table 2.3). 
       MosA crystals that grew in a trigonal space group were taken to the Advanced 
Photon Source in Illinois, and were diffracted on BioCARS beamline 14BMC using an 
ADSC detector.  A total of 360 images were collected with an oscillation of 1˚ per image  
around the phi axis.  A wavelength of 0.9 Å was used.  Data were finally integrated and 
scaled using HKL2000 (Otwinowski, Z. and Minor, W., 1997) (Table 2.3). 
 
2.2.5 Molecular Replacement 
       Molecular replacement was the method chosen to solve the structure of MosA from 
this data set as previous structures of DHDPSs had been solved with a sequence identity 
of 45%.  Molecular replacement was carried out using Phaser (McCoy et al., 2007).  
Final molecular replacement solutions can be found in Table 3.1 (pg. 36)     
 
2.2.6 Molecular Modeling of MosA 
       Starting with the E. coli model, non-identical residues were changed to the correct 
MosA sequence.  Modeling of the MosA structure was carried out using COOT (Emsley, 
P. and Cowtan, K., 2004) and refinement of the model was carried out using CNS 
(Brunger et al., 1998).  Refinement was carried out from 10.5 Å to 1.95 Å with 20 cycles 
of conjugate gradient minimization per round of refinement.  Final refinement statistics 
can be found in Table 3.2.      
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Table 2.3 Table of data processing statistics for MosA crystal data collections.  Numbers 
in parentheses refer to the highest resolution shell.      
 
 
MosA crystal  Orthorhombic  Trigonal   
Wavelength (Å) 1.33 (CLS) 0.90 (APS) 
Resolution limit (Å) 19.75 – 1.95 (2.00 – 1.95) 50-3.2 (3.31 – 3.2) 
Space group C 2 2 21 P 31
No. of molecules/asym unit 2 4 
Unit cell dimensions a = 68.9 Å 
b = 138.7 Å 
c = 123.2 Å 
a = 115.15 Å 
c = 95.94 Å 
Volume of unit cell (Å3) 1.18 x 106 1.10 x 106
Specific Volume (mL/g) 1.32 1.24 
No. of observed reflections 254154 241480 
No. of unique reflections 41799 23381 
Data redundancy 6.1 10.3 
Completeness (%) 93.4 (74.4) 99.7 (99.9) 
I/σ(I) 8.5 (3.9) 3.5 (3.8) 
Rsym 0.10 (0.26) 0.12 (0.32) 
Rsym is defined as Rsym = ∑│ I-<I>│/∑I, where I = individual intensity measured and  
<I> = average of symmetry-related intensities. 
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2.3 Comparison of MosA to other NAL Superfamily Members  
       For comparisons of MosA to other DHDPS structures in the protein data bank, 
DaliLite was used with homologous regions between MosA and the other DHDPSs being 
overlaid (Holm and Park, 2000). Root mean square deviation (r.m.s.d.) values were 
obtained by comparing protein backbone atoms of each subunit to its corresponding 
subunit in the search model as listed in Table 3.3 (pg. 40).   Matrices for transforming 
pdb coordinates for overlay pictures were generated by DaliLite (Holm and Park, 2000); 
pdbset, from the CCP4 suite, was used for the transformations (CCP4, 1994).  Pictures of 
the active site and other overlays were generated using Pymol (Delano, W. L., 2002).    
 
2.4   Dynamic Light Scattering 
       MosA protein in buffer containing 10  mM Tris-HCl pH 8.0, 50  mM KCl, 2  mM 2-
mercaptoethanol, and 5 mM pyruvate was filtered through a 0.1 µm Anodisc 13 filter 
(Whatman) and 20 µl was placed in the testing cuvette of the dynamic light-scattering 
instrument (DynaPro-MS800). Data were processed using the software supplied with the 
instrument (Dynamics v. 5.26.60, Protein Solutions Inc.). Measurements of the 
hydrodynamic radius were recorded at intervals from 277 to 318 K.  
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3.0   Results  
3.1   MosA 
3.1.1 Protein Purification 
       After following the procedure for protein purification laid out in Section 2.2.1, Chris 
Phenix in the Palmer laboratory washed the Ni 2+ affinity chromatography column with 
95% washing buffer (20 mM Tris buffer, pH 8.0, 5 mM imidazole, 500 mM NaCl, and 
12.5% v/v glycerol) and 5% elution buffer (washing buffer plus 100 mM EDTA).  This 
purified MosA almost to homogeneity as shown in Figure 3.1.  MosA protein was pooled 
from fractions, dialyzed as described in Section 2.2.1, and frozen as described in Section 
2.2.1. 
 
3.1.2   Crystallization and Cryoprotection 
       Orthorhombic crystals of MosA grew reproducibly overnight as described in Section 
2.2.2.  Single crystals grew as bipyramids to maximum dimensions of 0.3 x 0.3 x 0.5 mm 
(Figure 3.2).  These crystals were then soaked in cryoprotectant containing lysine and 
pyruvate as inhibitor and substrate, respectively.  Although other cryoconditions were 
tried, the best conditions were as mentioned in 2.2.3.   Crystal soaking conditions that 
used lower ammonium sulfate concentrations were unsuccessful due to the crystals 
cracking. 
       MosA crystals that grew in a trigonal space group using the same crystal growth 
conditions laid out in 2.2.3.  These crystals diffracted to 3 Å but were not pursued further 
since the orthorhombic crystals diffracted to a higher resolution. 
 30
 Figure 3.1  SDS-PAGE of MosA purification.  Top gel: Lane 1, insoluble pellet after 
sonication; Lane 2, soluble fraction after sonication; Lane 3, flow fraction 1; Lane 4, 
binding buffer wash; Lane 5, wash buffer fraction 1; Lane 6, protein molecular weight 
standards (Invitrogen) - molecular weight markers from top of gel as follows 1: 181.8 
kDa 2: 115.5 kDa 3: 82.2 kDa 4: 64.2 kDa (pink band) 5: 48.8 kDa 6: 27.1 kDa; Lane 7, 
wash fraction buffer 2; Lane 8, elution fraction 1; Lane 9, elution fraction 2; Lane 10, 
elution 3; Bottom gel: Lanes 1- 4, elution fractions 4-8; Lane 5, protein molecular weight 
standards; Lane 6 – 8, elution fractions 8 –10. 
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 Figure 3.2 Crystals of MosA.  Grown overnight in 2 M ammonium sulfate, 100 mM Tris 
buffer pH = 8.0, and 2% v/v PEG400, the crystals shown are 0.3 x 0.3 x 0.5 mm in size.   
     
3.1.3   Diffraction and Data Processing 
       Crystals were taken to the Canadian Light Source for diffraction.  The first crystal 
chosen diffracted to 2.2 Å.  After problem with the ring current at the CLS, another 
crystal was chosen for diffraction, as the first data set was incomplete.  Following 
restoration of the x-ray beam, a second crystal was diffracted to a resolution of 1.95 Å.  
This data set was processed as described in Section 2.2.4 and the structure solved as 
described in Section 2.2.5.   
 32
 Figure 3.3 Diffraction image from the MosA data collection.  Diffraction was observed 
out to 1.65Å and the data were cut off at 1.95 Å for completeness and merging R factor.  
 
3.1.4   Rotation and Translation Functions 
       A rotation search was performed using Phaser from the CCP4 suite of programs 
(McCoy et al., 2007).  A brute force likelihood method is employed by the program in 
searching with a starting model as described in Section 2.2.5.  A Patterson peak is found 
corresponding to one MosA protein monomer in the unit cell and is listed in Table 3.1 as 
1.  Once that solution was selected, brute force translation was used to then find the 
optimum translation function for the selected rotation.  Solutions are picked on the basis 
of a score assigned to them by Phaser (McCoy et al., 2007), and the log-likelihood gain 
of that solution.  The log-likelihood gain is the difference between the likelihood of the 
model and the likelihood calculated from a Wilson distribution.  The likelihood is thus 
defined as the probability of the data being measured, given the model consisting of the 
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atomic coordinates and the rotation and/or translation operators applied to those 
coordinates.  In simpler terms, the log-likelihood gain indicates how well the model can 
predict the data.  The log-likelihood gain should be positive and should increase as the 
solution progresses.  A Z-score is also attached to the solution, which is the number of 
standard deviations over the mean, the mean derived from a score assigned to five 
hundred random rotations and/or translations.  Larger Z-scores indicate more likely 
solutions, and should increase as the solution progresses.  Initial Z-scores are 
recommended to be over a value of eight.  
       Once one molecular solution was found, the location of this molecule was fixed.  
This selected solution was fitted and refined to the final rotation and translation values 
listed in Table 3.3 as Solution 1.  The process of rotating and translating was repeated to 
find the second molecule, as there are two molecules in the unit cell.  The Matthews 
coefficient was found to be 2.24, giving a solvent content of 45 % with two molecules in 
the asymmetric unit. Once both rotation and translation solutions were found, they were 
applied to the starting model and adjusted.  Final rotation and translation values are listed 
in Table 3.3.   
 
3.1.5   Refinement 
       Once the rotation and translation functions were applied to the starting model, 
refinement of that model was undertaken as described in Section 2.2.6.  The model had 
an initial R-factor of 41.5%, for both molecules of MosA, and refined successfully from 
19.75 – 1.95 Å.  The refinement calculations were done using CNS and were carried out 
after each round of model building (Brunger et al., 1998).  Final R-factor was 21.9% and 
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Rfree was 26.8%. The root mean square deviation (r.m.s.d.) for bond lengths and angles 
was 0.007 Å.  All final refinement statistics are shown in Table 3.2 (pg. 38) and the 
Ramachandran plot (Ramakrishnan and Ramachandran, 1965) shows the strained Y106 
conformation (Figure 3.4) (pg. 40). 
 
3.1.6   Structural Overlays 
       Overlays of MosA and several NAL family members were carried out using lsqkab.  
DHDPS structures from H. influenzae, T. maritima, M. tuberculosis, A. aeolicus and   
E. coli were superimposed with MosA from S. meliloti.  All r.m.s.d. values given in Table 
3.3 (pg. 41) are for the α carbons overlaid within the given residue range.  
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Table 3.1 Table of the best rotation and translation search results for MosA search 
models performed in the space group C 2 2 21.  Search performed by Phaser from the 
CCP4 suite (McCoy et al., 2007; CCP4, 1994).  *Log-likelihood gain (LLG). Initial 
solutions (top) and final solutions (bottom) for two molecules found in the asymmetric 
unit.  Solution number 3 represents the next highest solution (noise) peak. 
 
 
Solution 
number 
     α       β      γ  transX  transY  transZ LLG* Z-score 
1   165.2   30.9     97.9 0.908 0.389 0.167 169.95 7.47 
2       6.8   78.1      261.9 0.847 0.322 0.889 156.28 7.69 
3       2.1   62.2     53.3 0.637 0.682 0.553   15.09 4.39 
 
 
Solution 
number 
     α       β      γ  transX transY  transZ LLG* Z-score 
1 167.8    31.2    94.7 0.928 0.412 0.170 191.60 15.41 
2     7.1    77.7  262.9 0.838 0.307 0.889 169.65 15.01 
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Table 3.2 Final refinement statistics for MosA using CNS (Brunger et al., 1998).  
Numbers in parentheses refer to highest resolution shell. 
 
 
Resolution limits (Å) 10.5 – 1.95 (2.00 – 1.95) 
Rwork (37312 reflections) 0.219 (0.33) 
Rfree (2073 reflections) 0.268 (0.37) 
Rcryst (39385 reflections) 0.228 
No. of residues  584 
No. of non-hydrogen protein atoms 4408 
No. of water molecules 785 
Mean B factor main chain atoms (Å2)  20.6 
Mean B factor side chain atoms 22.9 
Mean B factor water molecules 34.1 
Mean B factor SO42- ions 31.1 
r.m.s.d. from ideal geometry 
Bond distances (Å) 
Bond angles (˚) 
Dihedral angles (˚) 
Improper angles (˚) 
 
0.007 
1.49 
21.8 
0.91 
Ramachandran plot regions 
Residues in most favoured regions (%) 
Residues in favoured (%) 
Residues in additional allowed regions (%) 
Residues in disallowed regions (%) 
 
91.2  
8.0  
0.4  
0.4 
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Rsym = Σ⏐〈Ihkl〉 - Ihkl⏐/⏐Ihkl⏐, where 〈 Ihkl〉 is the average intensity over symmetry-related 
reflections and Ihkl is the observed intensity. 
Rvalue = Σ⏐⏐Fo⏐ - ⏐Fc⏐⏐/Σ⏐Fo⏐, where Fo and Fc are the observed and calculated 
structure factors. For Rfree the sum is done on the test set reflections (5% of total 
reflections), for Rwork on the remaining reflections, and for Rcryst on all reflections 
included in the resolution range. 
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 Figure 3.4 Ramachandran plot for the structure of MosA complexed with pyruvate.  The 
red coloured region is the most favoured region, the yellow and light yellow represent 
favoured and additional favoured regions.  Shown in disallowed space are 2 residues, 
Y106 A and B.  Y106 has adopted a well documented strained conformation as seen in 
other DHDPS structures. 
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Table 3.3 Final backbone atom structural overlay values for MosA from S. meliloti and 
DHDPSs found in the Protein Data Bank.  All r.m.s.d. values generated from DaliLite 
(Holm and Park, 2000). 
 
 
PDB code Organism Residue Range % Identity r.m.s.d. (Å)
1DHP E.  coli 54-68; 74-124; 
159-175; 202-245;
251-259; 275-288 
45 1.2 
1YXD E. coli w/ lysine bound 54-68; 74-124; 
159-175; 202-245;
251-259; 275-288 
45 1.2 
1F5Z H. influenzae 58-72; 78-128; 
163-179; 205-249;
254-262; 279-292 
26 2.3 
1F73 H. influenza w/ sialic acid 58-72; 78-128; 
163-179; 205-249;
254-262; 279-292 
26 2.3 
1O5K T. maritima 65-79; 85-145; 
170-186; 213-256;
262-270; 286-299 
40 1.4 
1XXX M. tuberculosis 67-81; 87-147; 
172-188; 215-257;
264-272; 288-301 
34 1.6 
2EHH A. aeolicus 53-67; 73-123; 
158-174; 201-244;
250-258; 274-287 
43 1.3 
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3.1.7   Dynamic Light Scattering 
       Dynamic light scattering performed on MosA indicated a highly homogenous 
solution that was likely to be composed of tetramers, as are other DHDPSs. The data 
revealed a bimodal distribution with one highly monodisperse (<15% polydispersivity) 
peak comprising 99% of the mass and having an approximate hydrodynamic radius of 
4.2 nm, corresponding to a 130 kDa tetramer. The protein solution tolerated a change of 
temperature from 277 to 303  K. Above 318  K, the detector recorded an overload 
indicating a temperature limit had been reached, which was likely to coincide with 
denaturation of the protein.  
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4.0   Discussion 
4.1   MosA crystal structure 
4.1.1   Overall folding 
       The MosA protein is a tetramer in solution and in the crystal structure.  Four subunits 
come together to form the tetramer in alternating (β/α)8 packing in the crystal (Figure 
4.1). Consisting of eight parallel β-strands surrounded by eight α-helices, the TIM barrel 
was first described in triosephosphate isomerase (Banner et al., 1975; reviewed by 
Reardon and Farber, 1995).  Each monomer of MosA consists of a TIM barrel with two 
additional α-helices.  The tetramer then provides four active sites as well as a channel 
between dimers for substrate flow. 
 
4.1.2   Crystal Packing 
       In the space group C 2 2 21, the 21 screw axis is, by convention, along the c-axis. A 
2- fold symmetry is observed along the a and b axes (Figure 4.2).  Due to C-centering, 
additional 21 screw axes are observed at 0, 0, ¼; ¼, ¼, 0; ¼, 0, ¼; 0, ¼, ¼.  There are two 
molecules in the asymmetric unit and thus sixteen monomers in the unit cell.      
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 Figure 4.1 Stereo view of the MosA tetramer.  Visible is the overall TIM barrel folding 
and active site orientation.  Y106 reaches from one subunit into the adjacent one, linking 
the two subunits as seen above.  Pictured in spheres, key active site residue carbons are 
coloured in green, oxygens red, and nitrogens blue. 
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 45
 Figure 4.2 Crystal packing of MosA.  Depicted are unit cells as viewed down the a, b, 
and c axes of the unit cell.  Image made using TURBO-FRODO (Roussel, A. and 
Cambillau, C., 1990).  
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4.1.3   Active Site Geometry 
       The MosA active site is centered on residue K161 (Figure 4.3). In the first step of the 
lyase reaction, pyruvate is covalently attached to K161 in a dehydration step, resulting in 
an imine formation.  Y106, Y132, and T43 form a catalytic triad that is highly conserved 
in other DHDPSs.  Other DHDPS structures have reported the involvement of R137 in 
substrate binding.  In the structure reported here, R137 is located over 5 Å away from the 
nearest active site residue, Y132.  It is hypothesized this arginine is acting as a gatekeeper 
to the  active site hole that is located in the centre of the β-barrel (Dobson et al., 2005b).  
L-ASA binds after pyruvate, and a possible role for R137 centres on this second substrate 
binding (Figure 4.3, Figure 4.4). 
       K161, labelled to as LYP in the structure reported here with pyruvate bound in imine 
form, forms two hydrogen bonds with the side chain oxygens of T43 and T44.  A list of 
all hydrogen bonds in the active site can be found in Table 4.1.  There are another two 
hydrogen bonds formed with the peptide nitrogens of the same residues.  In addition, T43 
is highly conserved in the NAL superfamily.  This is unsurprising as hydrogen bonds are 
formed between it and the two tyrosines, Y106 and Y132, two of the key residues in the 
catalytic triad forming a proton relay.  It is also worth noting that Y106, stretching over 
from the other subunit in the dimer, shows a strained carbonyl oxygen conformation.  
This means the hydroxyl group is oriented toward T43 forming a hydrogen bond and 
positioning the tyrosine for proton transfer.  In addition to that, a hydrogen bond is 
formed between the strained carbonyl oxygen of Y106 and the epsilon nitrogen in R137.  
Proper positioning of the arginine for binding to L-ASA may thus be accomplished 
through the strained conformation adopted by Y106.  As well, proper positioning of 
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Y106 may be accomplished by R137, although the variability of R137’s position in 
previously solved structures and the inflexibility of Y106 lends credence to the role of 
Y106 in R137 alignment and not necessarily the other way around.   
 
4.1.4   Description of pyruvate Schiff base adduct 
       Covalently bound to the key active site residue K161 is pyruvate that has been 
converted to the imine form.  Located in close proximity to the catalytic triad, K161 is 
centered at the bottom of the hole created by the β-barrel (Figure 4.4).  This is the first 
time a pyruvate molecule has been reported in the active site of a DHDPS (Figure 4.5).    
The conversion to imine form lends credence to the previously postulated enzyme 
mechanism (Figure 1.8) (pg. 12). 
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Figure 4.3 Stereo view of the MosA active site.  Covalently bound to K161 following 
conversion to an imine is a pyruvate molecule.  R137 is pictured in the upper portion near 
Y132 at the opening of the active site. H-bonds are denoted as black dashes. 
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Table 4.1 Table of hydrogen bonds in the MosA active site. 
Residue  Residue Distance (Å) 
K161 O1 T44 OG 2.69 
K161 O1 T44 N 2.89 
K161 O2 T43 OG 3.13 
K161 O2 T43 N  3.05 
Y132 OH T43 OG 2.83 
Y106’ OH T43 OG 3.04 
Y106’ O R137 NE 2.45 
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 Figure 4.4 Surface view of the MosA dimer.  The active site is coloured in the centre by 
atom type, carbon being green, oxygen is red, and nitrogen blue.  The surface is coloured 
by secondary structure, with β-strands in pink and α-helices in light blue.  The active site 
is visible in the centre of the β-barrel hole.  The side chain of R137 is just visible on the 
right side of the hole, and in other MosA structures (not reported) is present over the 
active site indicating a possible gate-keeper role. 
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 Figure 4.5 Pyruvate bound at the MosA active site.  An omit map was calculated, 
following refinement, with the pyruvate adduct removed from the structure factor 
calculation and is shown here contoured at 3 σ. 
 
4.1.5   New Proposals for Enzyme Mechanism 
       Previous structures have reported waters or chloride ions bound in the active site.  As 
this structure has pyruvate covalently bound, a closer examination of the enzyme 
mechanism is possible.  The currently accepted mechanism involves formation of an 
imine of pyruvate with K161, which as discussed, is seen in this MosA structure.  In the 
proposed mechanism, Y132 acts as an acid and final stop in the proton relay between 
solvent and pyruvate.  Y132 is also involved in the subsequent reaction with L-ASA, 
acting again as an acid donating a proton, later regaining its proton acting as a base in a 
further reaction with the enzymatic product.  G186 is also involved in another important 
function, anchoring the L-ASA to the active site.  Eventually, G186 aids in product 
formation by orienting the para-hydroxyl group in the axial position of the 4-
hydroxytetrahydrodipicolinic acid.   
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       Binding of L-ASA may be facilitated by movement of R137 but without a crystal 
structure showing movement, this would be pure speculation.  It is believed that given the 
location of R137, and investigation of entropies by Dobson et al., the side chain of R137 
is highly likely to be involved (Dobson et al., 2005a).  Overlays between the E. coli 
structure and MosA do not show any significant difference in side chain location when 
pyruvate is bound, indicating a role in substrate movement in and out of the active site, or 
as mentioned above, a role in L-ASA binding.  Investigation with mutants of this amino 
acid would shed light on this debate.  
 
4.2   MosA and other DHDPSs 
4.2.1   E. coli DHDPS 
       Given the 45% amino acid sequence identity between E. coli DHDPS and S. meliloti 
MosA, the fact that their backbone atoms align to 1.2 Å is of little surprise.  Overall, the 
Cα trace can be superimposed as shown in Figure 4.6.  Even when superimposing MosA 
and E. coli DHDPS with added free lysine bound, the structure shows little difference, 
with an r.m.s.d. value of 1.2 Å (Table 3.3)(pg. 40) (Figure 4.6, 4.7, and 4.8). 
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Figure 4.6 Stereo diagram of the overlays of E. coli DHDPS (1DHP) and MosA 
backbone atoms.  MosA is depicted in green, E. coli DHDPS in blue.  
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4.2.1.1   Inhibition by lysine 
       The E. coli DHDPS structure reported by Dobson et al has two single lysine amino 
acids bound at allosteric sites (Figure 1.9 and 4.8) (Dobson et al., 2005b).  This is 
supported by work in the Palmer lab that shows binding of 2 lysines for every one 
pyruvate (Tam et al., 2004).  Binding of an inhibitor at an allosteric site did not confer 
any significant structural change to the active site.  Allosteric inhibitors, by definition, 
bind at a site in the enzyme away from the active site and lower the affinity of the 
enzyme for the substrates.  Previous investigation indicated that lysine might inhibit 
DHDPS by inhibiting R138 (E. coli numbering) movement (Blickling et al., 1997).  In 
the Dobson structure, this was found not to occur.   
       A second theory has been put forward regarding lysine inhibition.  In examining the 
structure of DHDPS from E. coli, researchers concluded that lysine inhibition was 
facilitated by blockage of a solvent channel, thereby trapping reaction end-products in the 
active site (Dobson et al., 2005b).  In the structure reported here, no such solvent channel 
can be found.  In addition, when overlaid with the Dobson structure, MosA with pyruvate 
bound shows neither significant side chain location difference, nor blockage of any 
channel (Table 3.3) (Figure 4.8).  This lack of movement is in agreement with work done 
by Chris Phenix in the Palmer laboratory (Phenix, 2007).   His investigation of MosA 
using isothermal titration calorimetry (ITC) revealed that lysine binding to MosA when 
pyruvate was bound was enthalpy driven.  This finding indicates that when pyruvate is 
present, enthalpic heat is being released that drives binding, not the exclusion of water 
molecules.  Indeed, when pyruvate is not bound to MosA, lysine binding is entropically 
driven, indicating water molecules in and around the allosteric binding site are released.   
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       The end result of the ITC work is that MosA binds lysine when pyruvate is bound 
because it is enthalpically favourable, not because it is entropically favourable.  The 
expulsion of waters from the active site or blockage of a solvent channel does not appear 
to be the mechanism of lysine inhibition.  What can be said is that lysine is a mixed 
inhibitor of MosA, binding to both E and ES complexes.  This supports kinetic work 
done by Dobson and contraindicates other work that shows lysine is an uncompetitive 
inhibitor with respect to pyruvate (Dobson et al., 2005b).  Overlaying the E. coli 
structure, with lysine bound, to this structure of MosA with pyruvate bound has not 
produced any clearer results, despite an r.m.s.d. of only 1.2 Å.  Without a structure of 
lysine and pyruvate bound to MosA, the mechanism of inhibition remains unresolved.  
 
 
Figure 4.7 MosA active site with E. coli DHDPS active site, with lysine bound (not 
pictured), overlaid.  Overall r.m.s.d. was 1.2 Å indicating a close alignment of alpha 
carbon atoms.  As pictured, overall side chain movement is essentially negligible.  MosA 
is shown in green, E. coli DHDPS in purple.  
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 Figure 4.8 MosA active site with relative location of the two solitary lysine amino acids 
from E. coli DHDPS superimposed.  Visible on the right, the two individual lysines are 
located in the allosteric binding site.  MosA is depicted in green, the lysines from E. coli 
DHDPS complex in blue. 
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4.2.2   Haemophilus influenzae N-acetylneuraminate lyase  
       MosA is a member of the NAL superfamily so while its reaction may differ from 
other family members; its structural framework is similar.  As such, structural alignments 
were carried out with a 2.3 Å r.m.s.d. between MosA and H. influenzae DHDPS.  Similar 
to the E. coli overlay, the Cα trace is very similar.  Overall folding remains the same with 
tetramers present and similar contacts made between interfaces.   
 
4.2.2.1   Inhibitor bound complexes 
       Lawrence et al., in 2000, reported structures with 3 substrate analogs, including sialic 
acid alditol (2,4,6,7,8,9-hexahydroxy-5-methylcarboxamido nonanoic acid : HMN) bound 
in the active site of H. influenzae NAL and not at the allosteric site (Figure 4.10).  The 
carboxylic acid group of the inhibitor aligns in the same location and orientation of the 
pyruvate carboxylic acid group bound in the MosA active site.  The inhibitor HMN, 
positioned in the MosA active site, makes hydrogen bonds with a conserved threonine 
residue seen in the MosA structure with pyruvate (Figure 4.10). 
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Figure 4.9 After overlapping backbone atoms of H. influenzae NAL with MosA, the 
stereo view of HMN (sialic acid) bound to the H. influenzae NAL, and the Schiff base 
adduct formed by lysine and pyruvate.  The HMN acts as an inhibitor in H. influenzae 
and is shown overlaid with K161 of MosA.  Of note, the two oxygens of HMN which 
overlap the pyruvate and lysine adduct oxygens in MosA, thereby making key hydrogen 
bonds and removing the possibility of pyruvate binding to the H. influenzae NAL active 
site.    
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Figure 4.10 After overlapping the backbone atoms of the protein structures, a stereo view 
of key active site residues from MosA and NAL from H. influenzae.  HMN, or sialic acid 
alditol, is also shown in its bound position, making key hydrogen bonds, shown in black.  
MosA is pictured in green, H. influenzae NAL in dark blue.  
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As mentioned, the inhibitors bound to the H. influenzae NAL structure bind 
directly in the active site, and in two cases directly to the active site lysine via covalent 
bond, so these overlapping atom sites are to be expected.  Of note in the sialic acid alditol 
(HMN) bound structure is the movement of key active site residues.  As shown in Figure 
4.10, Y136 is shown to be moved away from the inhibitor.  The mechanism of this 
inhibitor is two-fold.  First, simply by occupying the pyruvate binding site, and making 
key hydrogen bonds, HMN, in H. influenzae NAL, is able to inhibit the NAL reaction 
before the first step in the reaction.  The second method of action seems to involve 
displacement of key residues, in this case the active site lysine and tyrosine side chains, 
and would disrupt the stacking and proton transfer ability of the catalytic triad in the 
enzyme. This does confirm the ability of NAL superfamily members to be inhibited and 
lends further credence to the currently accepted mechanism of action for MosA.     
 
4.2.3   Other DHDPSs comparison to literature  
       The most studied DHDPS in the literature is from E. coli.  As mentioned in section 
3.1.6, structural overlays between A. aeolicus, M. tuberculosis, T. maritima, and H. 
influenzae were performed (Figure 1.5).  No significant changes or movements can be 
observed in the active site and overall folding shows the same TIM barrel motif and 
tetramer formation observed in MosA.  Interestingly, the one member of the family 
showing markedly different tetrameric arrangement has only one example.  DHDPS from 
N. sylvestris adopts the reverse quaternary formation from all other known DHDPSs 
(Blickling et al., 1997) (Figure 4.11).  
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Figure 4.11 Stereo view of the N. sylvestris DHDPS (top) (adapted from Blickling et al., 
1997) and MosA (bottom).  Active site residues are illustrated as spheres in N. sylvestris 
DHDPS and MosA.  The tetramer formation of N. sylvestris DHDPS is different from all 
other known DHDPSs.  As shown, MosA adopts the conformation observed in all other 
solved DHDPS structures.  Lettering denotes chain identifier. 
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       As seen in Figure 4.11, the dimer interface between subunits remains unchanged, but 
the tetramer interface is on the opposite side to as compared to MosA and to other 
DHDPSs.  This orients the active sites of N. sylvestris DHDPS out into the cytosol and 
significantly narrows the solvent channel between the dimer pairs.  The reasoning for 
adopting this conformation remains unknown, and catalytic efficiency remains 
unchanged. 
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5.0   Conclusions and Future Studies 
5.1   MosA from S. meliloti 
5.1.1   Enzymatic characterization 
       In this thesis, the crystal structure of MosA from S. meliloti is reported.  This enzyme 
was originally characterized as a methyltransferase (Rao et al., 1995).  A sequencing 
error was discovered and corrected, placing MosA in the NAL superfamily of enzymes as 
a DHDPS (Tam et al., 2004).  The structure reported here shows pyruvate, the first 
reactant in the DHDPS reaction, bound covalently to the active site.  There is no longer a 
question of MosA functioning as a methyltransferase.  The main reaction catalyzed is the 
DHDPS reaction, as confirmed by this crystal structure and work done in the Palmer lab 
using ITC. 
       The x-ray structure reported here also helped confirm the proposed mechanism of 
action for the DHDPS reaction.  The pyruvate is captured in the active site, forming an 
imine with K161, as predicted in the currently accepted mechanism (Figure 1.8) (pg. 12).  
In addition, hydrogen bonding and close proximity of conserved active site residues 
confirms their role in the catalytic triad and in the proposed proton relay in the 
mechanism.   
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5.1.2   MosA and other NAL superfamily members 
       In examining the similarities of MosA to other related enzymes, structural overlays 
were performed to shed light on key structural features.  All of the NAL superfamily 
enzymes that have had their Cα atoms overlaid within 2.3 Å r.m.s.d.  This similarity 
indicates the importance of the overall tetrameric structure as previously reported.  The 
TIM barrel motif allows solvent to flow into, and away from, the active site, and the 
“reaching across” of Y106 from one subunit to another, allows a tight dimer interface for 
proper orientation and enzymatic activity. 
 
5.1.3   MosA inhibition by lysine 
       Although attempts were made, the soaking of lysine in MosA crystals did not 
produce a visible adduct.  However, given the degree of similarity and overlay of 1.2 Å 
r.m.s.d., comparing the position of lysine in the E. coli DHDPS structure with MosA, 
reasonable theories can be formulated as to the mechanism of inhibition.  Also given that 
MosA is similar to other NAL family members, any inhibitor of MosA should likely be 
applicable in other organisms that are classified as pathogens, and thus MosA becomes a 
good structure for study in drug and herbicide development.  Although the exact 
mechanism is unknown, the structural data combined with ITC data make a case for 
disruption of aromatic stacking in the active site.  As seen in the NAL structure from H. 
influenzae, inhibitors acting in such a fashion can be successful.  Although lysine is an 
allosteric inhibitor, subtle changes in active site geometry may ultimately inhibit the 
DHDPS reaction.   
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5.2   Future work with MosA 
       The mechanism of lysine inhibition of MosA remains a question.  Any future work in 
this area should revolve around a structure containing both pyruvate and lysine.  As 
mentioned, crystal soaking in this case was unsuccessful, so co-crystallization remains as 
the best option for introduction of these ligands.  In addition, a structure with L-ASA 
bound may provide further insight or corroboration for the currently accepted enzyme 
mechanism.  There are questions remaining about the role of R137, specifically because 
it can be observed in a variety of locations in the active sites of the NAL family members 
whose structures have been solved.  In looking at a surface model of MosA, R137 is 
positioned over the active site cavity, making it ideal to bind L-ASA or cover the active 
site once L-ASA is bound.  Arginine has a flexible enough side chain to allow movement 
before and after product formation, making this amino acid another target for mutation 
studies, and making it a possible inhibitor target as well.   
       Future work with ITC may also provide enzymatic characterization in the absence of 
further crystal structures.  A mutant MosA with changes to known or suspected active 
site residues would have interesting binding affinities and enzyme kinetics.  ITC has 
proven to be a valuable tool for such examinations.  Work in the Palmer laboratory has 
already shown ITC can rule out interactions of potential substrates, and has proven 
enthalpically versus entropic driven interactions can provide insight to mechanism, even 
with a known crystal structure.        
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